Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy; D000818:Animals; D000951:Antigens, Neoplasm; D001428:Bacterial Vaccines; D006528:Carcinoma, Hepatocellular / Q000276:immunology* / Q000378:metabolism / Q000628:therapy; D002478:Cells, Cultured / Q000528:radiation effects; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007114:Immunization; D008113:Liver Neoplasms; D008297:Male; D009163:Mycobacterium bovis; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000378:metabolism; D011830:Radiation Effects; D013997:Time Factors; D014612:Vaccines / Q000528:radiation effects
D000951:Antigens, Neoplasm; D001428:Bacterial Vaccines; D014612:Vaccines